Under the Affordable Care Act (ACA), most private insurance plans have been required to cover all FDA-approved forms of contraception without cost-sharing since the 2013 plan year. An analysis of private insurance claims from 2006-2014 for women ages 13 to 45 found a small but statistically significant increase in insertions of long-acting reversible contraceptive (LARC) devices after the ACA's contraceptive mandate took effect.
To Counter Pain and Opioid Use in Women, Commentary Recommends a Physical Activity Research Agenda
In a new commentary in the journal Women’s Health Issues, a group of researchers notes that as many as one-third of U.S. and Canadian women suffer from chronic pain, and commonly prescribed opioid treatments come with substantial risks. National health agencies recommend physical activity as a nonpharmacologic pain management strategy, but health professionals don’t yet have enough information about the type and intensity of exercise to recommend for specific groups of patients, or how best to make physical activity accessible to those who could use it to manage chronic pain.
Blog: Why FDA Should Implement Some of the National Academies’ Recommendations for Making Medicines Affordable
As the National Academies of Sciences, Engineering, and Medicine points out in a recent report, Making Medicines Affordable: A National Imperative, the U.S. biopharmaceutical sector has been successful in developing and delivering effective drugs for improving health and fighting disease over the past decades. Many medical conditions that were long deemed untreatable can now be cured or managed effectively.
Health Care in Retail Settings: An Expert Panel Discussion
The number of retail health clinics is widely expected to continuing growing.
Pharma Gifts to Providers Result in More Branded, Expensive Prescriptions
Gifts of any size had an effect on prescribing, and larger gifts elicited a larger impact, according to study findings.